Russian Pharmaceutical Industry Leader

About Pharmasyntez

The Pharmasyntez group
The leading producer of socially important drugs in Russia
  • Our specialization is development and production of antitubercular, antineoplastic, antiretroviral medicines, and hospital antibiotics
  • Product Portfolio consists of 115 products
  • We produce medicines in all dosage forms: tablets, capsules, granules, infusion solutions, sterile powders, injectables
  • Our five high-technology factories are the powerful modern production base
  • We produce the high-quality and effective medicines demanded by modern medicine
  • We develop innovative medicines
  • We increase the share of domestic drugs in the Russian market due to replacement of the imported substitute products
Technologies and quality
We guarantee steadily high quality of the produced drugs which is based on:
  • modern high-technology equipment
  • compliance with the GMP standards
  • high qualified personnel
Production capacities

Pharmasyntez is a leader in production of antitubercular medicines. We produce almost all antitubercular medicines registered in Russia, including new generation medicines.

There are 115 products in Pharmasyntez portfolio. These include hospital antibiotics, antihyperglycemic medicines, and medicines for the treatment of tuberculosis, HIV, hepatitis, and oncological diseases.

Annual production is more than 70 million packs
  • Tablets 12000 mln
  • Capsules 1500 mln
  • Bottles 185 mln
  • Ampoules 78 mln
  • Solutions for infusions 34 mln
  • Granules 16 000 kg
  • Prefilled Syringes 34 mln
  • Gels/ointments/creams 18 mnl
  • Suppositories 49 mnl
Pharmasyntez is the leader in hospital deliveries

The medicines made in Russia constitute 72.8% in a segment of the public hospital procurements, which remains 33.5% in nowadays value.

Effective business

The main goal of the company is to form a reliable long-term partner relationships. We highly respect the principles of legality, conscientiousness, professionalism. These are the basis of effective and mutually beneficial cooperation both with Russian and the foreign pharmaceutical companies.

  • Effective business processes in construction
  • Experience in production sites creation
  • Advanced technologies in production and management
  • Wide experience in medicines registration
  • Representatives in all regions of Russia
  • Highly-developed distributor network – more than 50 traders are presenting company’s products at the Russian market and in the CIS countries
  • Own system of medicines promotion in the market
  • Original incentive system of sales
Research center
  • Transfer of technologies and establishing production of generics on own production sites
  • Development of original production technologies
  • Research, development of original medicines and deployment in medical practice
  • Powerful research base
  • Annual investments in development of innovative medicines - up to 500 million rubles
Responsible employer
Professional orientation work with school students and students of higher education institutions
  • Competitive candidates screen for target training
  • Training at the expense of the company
  • Target grants
  • Guaranteed employment
System work on advanced training of a personnel:
  • Annually more than 60 employees are trained
  • Annual investments in personnel development are more than 1 million rubles
People care
  • The staff is provided with sanatorium and rehabilitation and recovery treatment by VHI and according to the results of the performed medical examinations
  • There is a big dining hall opened in 2017 which operates during the complete working cycle and completely corresponds to the production schedule of the plant. At the same time, the company partially covers employees’ expenses on food.
  • There have been created more than 300 new workplaces for the last three years
  • The average monthly salary level is 36 thousand rubles
Our partners
Apotex
Biocon
Dong-A ST
Oasmia
Orion Pharma
Reliance